drugset / Trial / NCT05114460
Vaped Marijuana to Attenuate Naloxone-Precipitated Withdrawal
RandomizedSequentialDouble-blindBasic science
Summary
The goal of the proposed, proof-of-concept study is to test the combined effects of vaporized marijuana \[Delta-9-tetrahydracannabinol (THC)\] with NLX as a proof of concept towards the possible development of a combined overdose reversal agent with improved tolerability.
Timeline
- Start
- 2021-11-01
- Primary completion
- 2024-10-15
- Completion
- 2024-10-29
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cannabis | Traditional medicine (herbal / TCM) | 0 mg | Inhaled |
| Subject | Cannabis | Traditional medicine (herbal / TCM) | 12.5 mg | Inhaled |
| Subject | Cannabis | Traditional medicine (herbal / TCM) | 25 mg | Inhaled |
| Subject | Naloxone | Small molecule | 0 mg | Intranasal |
| Subject | Naloxone | Small molecule | 4 mg | Intranasal |